[{"indications": "Indications\u00a0tuberculosis, in combination with other drugs; adjunct to doxycycline in brucellosis; enterococcal endocarditis (Table\r\n1, section 5.1)", "name": "STREPTOMYCIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.9 Antituberculosis drugs"], "cautions": "Cautions\u00a0see under Aminoglycosides, section 5.1.4; interactions: Appendix 1 (aminoglycosides)", "side-effects": "Side-effects\u00a0see under Aminoglycosides, section 5.1.4; also\r\nhypersensitivity reactions, paraesthesia of mouth", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3923.htm", "doses": ["By deep intramuscular injection,\r\ntuberculosis  [unlicensed], 15\u00a0mg/kg (max. 1\u00a0g) daily (reduced in\r\nthose under 50\u00a0kg, those over 40 years, or those with renal impairment)", "Brucellosis, expert advice essential", "Side-effects increase after\r\na cumulative dose of 100\u00a0g, which should only be exceeded in exceptional\r\ncircumstances", "One-hour (\u2018peak\u2019) concentration should be\r\n15\u201340\u00a0mg/litre; pre-dose (\u2018trough\u2019) concentration should be less than\r\n5\u00a0mg/litre (less than 1\u00a0mg/litre in renal impairment or in those over\r\n50 years)"], "pregnancy": "Pregnancy\u00a0see under Aminoglycosides, section 5.1.4"}]